Letter of Support from Takeda Pharmaceuticals
Takeda Pharmaceuticals has released a letter in support of the 340B Program. Click here to read it.
February 16, 2019
Takeda Pharmaceuticals has released a letter in support of the 340B Program. Click here to read it.
Biogen Idec has released a letter in support of the 340B Program. Click here to read it.
National Hemophilia Foundation has released a letter in support of the 340B Program. Click here to read it.
Pfizer has released a letter in support of the 340B Program. Click here to read it.
Novo Nordisk has released a letter in support of the 340B Program. Click here to read it.
CSL Behring has released a letter in support of the 340B Program. Click here to read it.
Grifols has released a letter in support of the 340B Program. Click here to read it.
Bioverativ has released a letter in support of the 340B Program. Click here to read it.
Aptevo Therapeutics has released a letter in support of the 340B Program. Click here to read it.
Octapharma has released a letter in support of the 340B Program. Click here to read it.